BioLight Life Sciences Ltd. BOLT.TA Stock
BioLight Life Sciences Ltd. Price Chart
BioLight Life Sciences Ltd. BOLT.TA Financial and Trading Overview
BioLight Life Sciences Ltd. stock price | 359.6 ILA |
Previous Close | 585 ILA |
Open | 585 ILA |
Bid | 595.3 ILA x 70000 |
Ask | 595.4 ILA x 74800 |
Day's Range | 596 - 596.7 ILA |
52 Week Range | 6.83 - 1039 ILA |
Volume | 260 ILA |
Avg. Volume | 3.49K ILA |
Market Cap | 27.31M ILA |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.6 ILA |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BOLT.TA Valuation Measures
Enterprise Value | 27.54M ILA |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 51.35996 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
BioLight Life Sciences Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -37.11% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1039 ILA |
52 Week Low | 6.83 ILA |
50-Day Moving Average | 608.5 ILA |
200-Day Moving Average | 770.67 ILA |
BOLT.TA Share Statistics
Avg. Volume (3 month) | 3.49K ILA |
Avg. Daily Volume (10-Days) | 11.1K ILA |
Shares Outstanding | 4.56M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 56.68% |
% Held by Institutions | 9.12% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 0.01 ILA |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 63K ILA |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -1.77 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 11.618 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of BioLight Life Sciences Ltd.
Country | Israel |
State | N/A |
City | Tel Aviv |
Address | Park Atidim |
ZIP | 6158101 |
Phone | 972 7 327 53400 |
Website | https://bio-light.co.il |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 5 |
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company's ophthalmic product offering and pipeline of product candidates include DiagnosTear's TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.
Q&A For BioLight Life Sciences Ltd. Stock
What is a current BOLT.TA stock price?
BioLight Life Sciences Ltd. BOLT.TA stock price today per share is 359.6 ILA.
How to purchase BioLight Life Sciences Ltd. stock?
You can buy BOLT.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioLight Life Sciences Ltd.?
The stock symbol or ticker of BioLight Life Sciences Ltd. is BOLT.TA.
Which industry does the BioLight Life Sciences Ltd. company belong to?
The BioLight Life Sciences Ltd. industry is Biotechnology.
How many shares does BioLight Life Sciences Ltd. have in circulation?
The max supply of BioLight Life Sciences Ltd. shares is 46.58K.
What is BioLight Life Sciences Ltd. Price to Earnings Ratio (PE Ratio)?
BioLight Life Sciences Ltd. PE Ratio is now.
What was BioLight Life Sciences Ltd. earnings per share over the trailing 12 months (TTM)?
BioLight Life Sciences Ltd. EPS is -5.6 ILA over the trailing 12 months.
Which sector does the BioLight Life Sciences Ltd. company belong to?
The BioLight Life Sciences Ltd. sector is Healthcare.